Literature DB >> 26807311

Impact of prospero homeobox-1 on tumor cell behavior and prognosis in colorectal cancer.

Young-Lan Park1, Eun Myung1, Sun-Young Park1, Nuri Kim1, Chan-Young Oak1, Dae-Seong Myung1, Sung-Bum Cho1, Wan-Sik Lee1, Sun-Seog Kweon2, Hyun-Soo Kim1, Young-Eun Joo1.   

Abstract

Prospero homeobox 1 (PROX1) is up-regulated in colorectal cancer and plays an oncogenic role. In the present study, we sought to investigate the impact of PROX1 on oncogenic processes and to assess the prognostic value of PROX1 expression in colorectal cancer. A small interfering RNA or pcDNA6-myc vector was used to control PROX1 gene expression in colorectal cancer DLD1 and SW480 cell lines. The expression of PROX1 in colorectal cancer tissues was investigated by immunohistochemistry. Angiogenesis, lymphangiogenesis, and tumor cell proliferation were assessed by analyzing the expression of respective markers of these phenomena, CD34, D2-40, and Ki-67 after immunohistochemical staining. PROX1 knockdown decreased both umbilical vein endothelial cell invasion and tube formation, down-regulated the expression of VEGF-A and HIF-1α, and up-regulated the expression of angiostatin. Lymphatic endothelial cell invasion and tube formation as well as the expression of VEGF-C were also suppressed by PROX1 knockdown. PROX1 knockdown suppressed tumor cell proliferation, migration, invasion, and epithelial-mesenchymal transition. In contrast, PROX1 overexpression enhanced tumor cell angiogenesis, lymphangiogenesis, proliferation, migration, invasion, and epithelial-mesenchymal transition. Levels of phosphorylated Akt, GSK3β, and MAPK were decreased by PROX1 knockdown and increased by PROX1 overexpression. PROX1 expression positively correlated with tumor size, extent of differentiation, lymphovascular invasion, depth of invasion, lymph node metastasis, stage, and poor survival. The mean microvessel density and Ki-67 labeling index values of PROX1-positive tumors were significantly higher than those of PROX1-negative tumors. However, there was no significant correlation between PROX1 expression and lymphatic vessel density. These results indicate that PROX1 influences tumor progression in colorectal cancer by regulating angiogenesis and tumor cell proliferation.

Entities:  

Keywords:  Prospero homeobox 1; angiogenesis; colorectal neoplasm; prognosis; proliferation

Year:  2015        PMID: 26807311      PMCID: PMC4697677     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  37 in total

1.  Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors.

Authors:  Markku Miettinen; Zeng-Feng Wang
Journal:  Am J Surg Pathol       Date:  2012-03       Impact factor: 6.394

Review 2.  Angiogenesis and the tumor microenvironment: vascular endothelial growth factor and beyond.

Authors:  Kriti Mittal; John Ebos; Brian Rini
Journal:  Semin Oncol       Date:  2014-02-28       Impact factor: 4.929

3.  Expression of PROX1 Is a common feature of high-grade malignant astrocytic gliomas.

Authors:  Tamador Elsir; Anna Eriksson; Abiel Orrego; Mikael S Lindström; Monica Nistér
Journal:  J Neuropathol Exp Neurol       Date:  2010-02       Impact factor: 3.685

Review 4.  Oncogenic roles of EMT-inducing transcription factors.

Authors:  Alain Puisieux; Thomas Brabletz; Julie Caramel
Journal:  Nat Cell Biol       Date:  2014-06       Impact factor: 28.824

Review 5.  The role of epithelial-mesenchymal transition in cancer pathology.

Authors:  Marcello Guarino; Barbara Rubino; Gianmario Ballabio
Journal:  Pathology       Date:  2007-06       Impact factor: 5.306

6.  Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer.

Authors:  Beatrix Versmold; Jörg Felsberg; Thomas Mikeska; Denise Ehrentraut; Juliane Köhler; Juergen A Hampl; Gabriele Röhn; Dieter Niederacher; Beate Betz; Martin Hellmich; Torsten Pietsch; Rita K Schmutzler; Andreas Waha
Journal:  Int J Cancer       Date:  2007-08-01       Impact factor: 7.396

7.  Expression and prognostic value of transcription factor PROX1 in colorectal cancer.

Authors:  M Skog; P Bono; M Lundin; J Lundin; J Louhimo; N Linder; T V Petrova; L C Andersson; H Joensuu; K Alitalo; C H Haglund
Journal:  Br J Cancer       Date:  2011-10-04       Impact factor: 7.640

Review 8.  Cancer stem cells--the current status of an old concept: literature review and clinical approaches.

Authors:  Lukasz Fulawka; Piotr Donizy; Agnieszka Halon
Journal:  Biol Res       Date:  2014-12-10       Impact factor: 5.612

Review 9.  Clinical application of genetics in management of colorectal cancer.

Authors:  Eun Ran Kim; Young-Ho Kim
Journal:  Intest Res       Date:  2014-07-25

10.  Clinicopathological characteristics of colon cancer diagnosed at primary health care institutions.

Authors:  Sang Hyun Park; Chi Wook Song; Yun Bae Kim; Young Sun Kim; Hwang Rae Chun; Jung Hyun Lee; Won Jong Seol; Hyung Sun Yoon; Myung Kwon Lee; Jong Hyup Lee; Choon Sang Bhang; Jae Hyung Park; Ji Young Park; Byung Hun Do; Young Dae Park; Sang Jeong Yoon; Chan Wook Park; Su Mi Yoon; Jong Hwan Choi; Ki Chul Shin; Dong Hoon Ko; Young Jin Kim; Dong Choon Seol
Journal:  Intest Res       Date:  2014-04-29
View more
  7 in total

1.  Concordant expression pattern across multiple immune tissues of commercial broilers in response to avian pathogenic Escherichia coli (APEC).

Authors:  Hongyan Sun; Huan Li
Journal:  3 Biotech       Date:  2019-08-05       Impact factor: 2.406

2.  SCARA5 plays a critical role in the progression and metastasis of breast cancer by inactivating the ERK1/2, STAT3, and AKT signaling pathways.

Authors:  Kai You; Fei Su; Lihua Liu; Xiaohong Lv; Jianguo Zhang; Yafang Zhang; Baoquan Liu
Journal:  Mol Cell Biochem       Date:  2017-05-11       Impact factor: 3.396

3.  miR-489 acts as a tumor suppressor in human gastric cancer by targeting PROX1.

Authors:  Bin Zhang; Sheqing Ji; Fei Ma; Qi Ma; Xianzhi Lu; Xiaobing Chen
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

4.  PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.

Authors:  Kapo Saukkonen; Jaana Hagström; Harri Mustonen; Anne Juuti; Stig Nordling; Pauliina Kallio; Kari Alitalo; Hanna Seppänen; Caj Haglund
Journal:  BMC Cancer       Date:  2016-07-13       Impact factor: 4.430

Review 5.  The Role of PROX1 in Neoplasia: A Key Player Often Overlooked.

Authors:  Evangelia Ntikoudi; Alexandros Pergaris; Stylianos Kykalos; Ekaterini Politi; Stamatios Theocharis
Journal:  Diagnostics (Basel)       Date:  2022-07-04

6.  The role of prospero homeobox 1 (PROX1) expression in follicular thyroid carcinoma cells.

Authors:  Magdalena Rudzinska; Joanna K Ledwon; Damian Gawel; Justyna Sikorska; Barbara Czarnocka
Journal:  Oncotarget       Date:  2017-12-12

7.  Transcription Factor Prospero Homeobox 1 (PROX1) as a Potential Angiogenic Regulator of Follicular Thyroid Cancer Dissemination.

Authors:  Magdalena Rudzińska; Michał Mikula; Katarzyna D Arczewska; Ewa Gajda; Stanisława Sabalińska; Tomasz Stępień; Jerzy Ostrowski; Barbara Czarnocka
Journal:  Int J Mol Sci       Date:  2019-11-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.